Consainsights logo
Mail Us
Reports > Life Sciences > Veterinary Cro Market Report

Veterinary Cro Market Size, Share, Industry Trends and Forecast to 2033

This report provides an in-depth analysis of the Veterinary Contract Research Organization (CRO) market, offering insights into market size, growth potential, key players, and trends from 2023 to 2033.

Metric Value
Study Period 2023 - 2033
2023 Market Size $2.50 Billion
CAGR (2023-2033) 7.3%
2033 Market Size $5.16 Billion
Top Companies Covance, Charles River Laboratories, Labcorp
Last Modified Date 15 Nov 2024

Veterinary Cro Market Report (2023 - 2033)

Veterinary Cro Market Overview

The Veterinary CRO industry is undergoing a transformation driven by advancements in biotechnology, increased globalization of clinical trials, and a growing emphasis on animal welfare. The industry is marked by a diversifying client base, including pharmaceutical companies, biotechnology firms, and academic institutions. These stakeholders are increasingly relying on CROs to enhance efficiency and accelerate the drug development process. Additionally, there is a surge in collaboration between CROs and technology firms to integrate digital solutions, such as data management systems and online platforms, that improve the speed and quality of research outcomes.

What is the Market Size & CAGR of Veterinary Cro market in 2023-2033?

As of 2023, the Veterinary CRO market is estimated to be valued at approximately $3.99 billion, with a projected compound annual growth rate (CAGR) of 8.6% through 2033. This growth is attributed to several factors, including increasing regulatory requirements for veterinary product approvals, heightened demand for animal health products, and advancements in veterinary medicine and treatments. Furthermore, the rising prevalence of zoonotic diseases and the need for effective veterinary pharmaceuticals drive demand for CRO services, making them indispensable in the veterinary drug development process.

Veterinary Cro Industry Analysis

The Veterinary CRO industry is undergoing a transformation driven by advancements in biotechnology, increased globalization of clinical trials, and a growing emphasis on animal welfare. The industry is marked by a diversifying client base, including pharmaceutical companies, biotechnology firms, and academic institutions. These stakeholders are increasingly relying on CROs to enhance efficiency and accelerate the drug development process. Additionally, there is a surge in collaboration between CROs and technology firms to integrate digital solutions, such as data management systems and online platforms, that improve the speed and quality of research outcomes.

Veterinary Cro Market Segmentation and Scope

The Veterinary CRO market is segmented based on service type, animal type, and study phase. By service type, the market encompasses preclinical services, clinical services, and laboratory services, with preclinical services holding the largest share due to the high demand for early-stage research. Animal types include companion animals, food animals, and exotic animals, which illustrate the varying needs across different veterinary sectors. The study phase segmentation breaks down into discovery phase, development phase, and post-market phase, reflecting the distinct requirements and timelines for veterinary drug development at different levels.

Request a custom research report for industry.

Veterinary Cro Market Analysis Report by Region

Europe Veterinary Cro Market Report:

Europe's Veterinary CRO market is expected to grow from $0.73 billion in 2023 to $1.50 billion by 2033. This increase is attributed to stringent regulatory requirements enhancing the need for CRO services, along with a high level of pet ownership and advanced veterinary care practices.

Asia Pacific Veterinary Cro Market Report:

The Asia Pacific region is emerging as a key market for Veterinary CROs, expected to grow from $0.51 billion in 2023 to $1.06 billion by 2033. This growth is driven by increasing livestock production, rising disposable incomes, and heightened awareness of animal health issues. Furthermore, investments in veterinary research from both governmental and private sectors are propelling the market forward.

North America Veterinary Cro Market Report:

North America, a leading region in the Veterinary CRO market, is forecasted to increase from $0.85 billion in 2023 to $1.76 billion by 2033. The region's established infrastructure, advanced technology, and robust investment in veterinary research create a favorable environment for CRO growth. Additionally, the rising pet ownership trend drives demand for innovative veterinary medicines.

South America Veterinary Cro Market Report:

In South America, the Veterinary CRO market is projected to expand from $0.09 billion in 2023 to $0.20 billion by 2033, spurred by growing demand for food animals and enhanced veterinary practices. The Brazilian market, in particular, is a focal point due to its large agricultural sector and commitment to animal health.

Middle East & Africa Veterinary Cro Market Report:

The Middle East and Africa region is anticipated to expand from $0.31 billion in 2023 to $0.64 billion by 2033. Growth is being driven by improvements in agricultural practices and the rising importance of animal health as a public health issue, particularly in the context of zoonotic diseases.

Request a custom research report for industry.

Veterinary Cro Market Analysis By Service Type

Global Veterinary CRO Market, By Service Type Market Analysis (2023 - 2033)

In 2023, the Veterinary CRO market by service type is led by preclinical services, valued at $1.64 billion, and expected to grow to $3.38 billion by 2033. Clinical services and laboratory services also exhibit strong growth potential, reflecting their critical roles in research and development processes.

Veterinary Cro Market Analysis By Animal Type

Global Veterinary CRO Market, By Animal Type Market Analysis (2023 - 2033)

The market for companion animals dominates the Veterinary CRO landscape, constituting 65.47% of the share in 2023, with a market size of $1.64 billion, expanding to $3.38 billion by 2033. Food animals and exotic animals follow, highlighting the detailed segmentation and distinct requirements across the various animal health sectors.

Veterinary Cro Market Analysis By Study Phase

Global Veterinary CRO Market, By Study Phase Market Analysis (2023 - 2033)

The discovery phase of veterinary drug development remains predominant, holding a 65.47% market share in 2023, valued at $1.64 billion and set to grow to $3.38 billion by 2033. This segment's significance reflects the innovative focus in veterinary medicine, with a strong pipeline of new products being explored.

Veterinary Cro Market Analysis By End User

Global Veterinary CRO Market, By End-User Market Analysis (2023 - 2033)

Pharmaceutical companies represent a major end-user within the Veterinary CRO market, with a size of $1.64 billion in 2023. Their reliance on CROs for effective research and development contributes significantly to the market's growth projections, further driven by increasing competition in the pharmaceutical industry.

Veterinary Cro Market Trends and Future Forecast

As we look toward the future, the Veterinary CRO market is expected to see sustained growth, driven by technological innovations such as AI and data analytics, enabling more efficient drug development processes. Additionally, the increasing emphasis on personalized veterinary medicine and advancements in biologics and regenerative therapies will shape market dynamics. However, challenges such as regulatory hurdles and market competition will require CROs to adapt quickly to meet changing industry demands. The market's robust growth is anticipated to continue through 2033, supported by investment in research and development across the veterinary sector.

Request a custom research report for industry.

Global Market Leaders and Top Companies in Veterinary Cro Industry

Covance:

Covance is a global leader in drug development services, providing comprehensive support to pharmaceutical and biotechnology companies including notable expertise in veterinary clinical trials.

Charles River Laboratories:

Charles River Laboratories is a prominent contract research organization offering a range of services, including preclinical and clinical studies, well established in the veterinary CRO sector.

Labcorp:

Labcorp excels in providing comprehensive laboratory services and has a strong portfolio in veterinary testing, supporting drug development processes for various veterinary applications.

We're grateful to work with incredible clients.

Datasite
Agilent
Asten Johnson
Bio-Rad
Carl Zeiss
Dywidag
Illumina
LEK Consulting
Shell

Related Industries

    FAQs